| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/03/2003 | WO2003027232A2 Method for producing biologically active products |
| 04/03/2003 | WO2003027146A1 Use of cardiotrophin in hepatic diseases |
| 04/03/2003 | WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 04/03/2003 | WO2003026714A1 Porous ceramic composite bone grafts |
| 04/03/2003 | WO2003026688A1 Biphasic liposomes containing immunogen and cpg, for stimulating an immune response |
| 04/03/2003 | WO2003026687A1 Delivery system for biological component |
| 04/03/2003 | WO2003026683A1 Health caring product for enhancing immunity and delaying aging |
| 04/03/2003 | WO2003026682A1 Use of a composition based on fish soft roe |
| 04/03/2003 | WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | WO2003026580A2 Interactive therapeutic enclosures |
| 04/03/2003 | WO2003026579A2 Combination therapies for immune mediated diseases |
| 04/03/2003 | WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | WO2002102305A3 Adjuvant composition for mucosal and injection delivered vaccines |
| 04/03/2003 | WO2002088336A3 Genetically modified yt cell line and use thereof |
| 04/03/2003 | WO2002074912A3 Tissue engineering enhanced by the transfer of a growth factor gene |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/03/2003 | WO2002033053A3 Method for enhancing primordial germ cell number |
| 04/03/2003 | WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 04/03/2003 | WO2002010357A3 Gsk3 polypeptides |
| 04/03/2003 | WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/03/2003 | US20030065149 Stabilized hemoglobin solutions |
| 04/03/2003 | US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 04/03/2003 | US20030064927 Regeneration of soft tissue; wound healing agents |
| 04/03/2003 | US20030064919 Novel polypeptides and polynucleotides encoding same |
| 04/03/2003 | US20030064511 Chondrocyte cells for use in the treatment of arthritic and bone disorders |
| 04/03/2003 | US20030064510 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity |
| 04/03/2003 | US20030064503 Device |
| 04/03/2003 | US20030064412 123 human secreted proteins |
| 04/03/2003 | US20030064118 Combination of Ginseng and Ginkgo to improve cognitive skills |
| 04/03/2003 | US20030064116 To enhance the nutritional value of the food consumed by mammals including humans and animals |
| 04/03/2003 | US20030064110 Method and composition for treating aphthous stomatitis |
| 04/03/2003 | US20030064096 Flavored gelatin capsule and method of manufacture |
| 04/03/2003 | US20030064089 Regenerated cellulose and oxidized cellulose membranes as potential biodegradable platforms for drug delivery and tissue engineering |
| 04/03/2003 | US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | US20030064059 Embryonic stem cells, clinical applications and methods for expanding in vitro |
| 04/03/2003 | US20030064058 Methods of utilizing bone marrow stem cells for inducing immunological tolerance |
| 04/03/2003 | US20030064057 Administering hematopoietic stem cells to the patient via intravenous injection; administering neuronal stem cells to the patient via subcutaneous injection for improving athletic performance and increasing lean muscle mass in a patient |
| 04/03/2003 | US20030064056 Enhanced submucosal tissue graft constructs |
| 04/03/2003 | US20030064022 Labeling human embryonic stem cells with a biocompatible label; administering labeled embryonic stem cells to patient via intravenous injection; detecting labeled embryonic stem cells to thereby identify the region of disease state |
| 04/03/2003 | US20030062318 Improved systems for collecting cellular-rich concentrates from blood components in a way that lends itself to use in high volume, on line blood collection environments, where higher yields of platelets can be realized |
| 04/03/2003 | US20030062314 Method and apparatus for magnetically separating selected particles, particularly biological cells |
| 04/03/2003 | CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2778208A1 Delivery system for biological component |
| 04/03/2003 | CA2462619A1 Tailor-made multifunctional stem cells and utilization thereof |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | CA2461666A1 Combination therapies for immune mediated diseases |
| 04/03/2003 | CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | CA2461290A1 Modulation of stem cells using zinc finger proteins |
| 04/03/2003 | CA2461121A1 Multipotent stem cell in the interstitial tissues of skeletal muscle |
| 04/03/2003 | CA2461007A1 Use of cardiotrophin in liver diseases |
| 04/03/2003 | CA2460575A1 Enzymatic conversion of blood group a, b, and ab red blood cells using .alpha.-n-acetylgalactosaminidases and .alpha.-galactosidases with unique substrate specificities and kinetic properties |
| 04/03/2003 | CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/02/2003 | EP1298208A2 Ribozymes targeting a hiv tat sequence |
| 04/02/2003 | EP1298203A2 Diagnosis and treatment of autoimmune diseases |
| 04/02/2003 | EP1298202A2 Biological factors and neural stem cells |
| 04/02/2003 | EP1298201A1 Process for the production of cells exhibiting an islet-beta-cell-like state |
| 04/02/2003 | EP1298139A2 Avian herpes virus-based recombinant infectious bursal disease vaccine |
| 04/02/2003 | EP1297121A2 Purging of cells using viruses |
| 04/02/2003 | EP1297120A2 Liver-specific gene expression cassettes, and methods of use |
| 04/02/2003 | EP1297119A2 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 04/02/2003 | EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 04/02/2003 | EP1296724A1 Bioadhesive composition and methods of preparation and use |
| 04/02/2003 | EP1296711A2 Human papilloma virus treatment |
| 04/02/2003 | EP1296695A2 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 04/02/2003 | EP1296694A1 Probiotics in primary prevention of atopic diseases |
| 04/02/2003 | EP1296693A1 Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296669A1 COMBINATION PREPARATION CONSISTING OF $g(V)-3-FATTY ACIDS AND OF CONJUGATED LINOLEIC ACIDS FOR TREATING IMMUNOLOGICALLY ORIENTED CLINICAL SIGNS |
| 04/02/2003 | EP1296636A1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES |
| 04/02/2003 | EP1296567A2 Diet which induces ketosis in a canine or feline |
| 04/02/2003 | EP1263448A4 Maca and antler for augmenting testosterone levels |
| 04/02/2003 | EP1135145B1 Isolated material having an anti-organotrophic effect |
| 04/02/2003 | EP0804283B1 Aqueous solvent encapsulation method and microcapsules |
| 04/02/2003 | EP0762897B1 Method of preventing aggregation of proteins/peptides upon rehydration or thawing |
| 04/02/2003 | EP0716697B1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 04/02/2003 | EP0696326B1 Use of NDV in the manufacture of a medicament for treating cancer |
| 04/02/2003 | EP0621865B1 Rapamycin derivative and its medicinal use |
| 04/02/2003 | EP0566732B1 Adeno-associated virus-2 basal vectors |
| 04/02/2003 | EP0561890B1 Dna expression systems based on alphaviruses |
| 04/02/2003 | CN1408022A Recombinant adenoviruses for sodium/iodide symporter (NIS) |
| 04/02/2003 | CN1407857A 低聚糖混合物 Oligosaccharide mixture |
| 04/02/2003 | CN1407853A Device and method for performing biological modification of fluid |
| 04/02/2003 | CN1407108A Genetic engineering recombination strain expression of lactoferritin and use thereof |
| 04/02/2003 | CN1407088A Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
| 04/02/2003 | CN1406631A Establishment of drug production system by non-virus bio-technology |
| 04/02/2003 | CN1406621A Medicines for treating psoriasis |
| 04/02/2003 | CN1406620A Patent Chinese medicine and preparing process for deficiency syndrome |
| 04/02/2003 | CN1406604A Chinese medicine for treating eye diseases |
| 04/02/2003 | CN1406598A Oral cavity ulcer powder and preparation thereof |
| 04/02/2003 | CN1406589A Insect health-care products for liver and stomach and preparation thereof |
| 04/02/2003 | CN1406588A Nano-propolis soliquoid preparation |
| 04/02/2003 | CN1406523A Oral liquid production |
| 04/02/2003 | CN1406515A Health-care food or medicine for reducing blood sugar |
| 04/02/2003 | CN1406505A Sesame paste with various vitamins and preparation thereof |
| 04/02/2003 | CN1406489A Collagen-DNA-Ag composition with bacteriostatic function and preparation thereof |
| 04/02/2003 | CN1406467A Milk with sensitinogen for treating anaphylaxis |
| 04/02/2003 | CN1104254C Medicinal liquid for treating bone fracture |
| 04/02/2003 | CN1104253C Medicine for strengthening physique and strengthening immunity |